FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06689956

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicente…

This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients…

United States, Austria, Brazil212 participantsStarted 2024-12-04

Treatment: Non-Interventional Study

All recent trials (11 shown)

Active — Not RecruitingPhase 1

NCT04092270

A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansi…

This phase I trial studies the side effects and best dose of peposertib when given together with pegylated liposomal doxorubicin hydrochloride in treating patie…

United States54 participantsStarted 2020-05-07

Treatment: Biospecimen Collection, Computed Tomography

Not Yet RecruitingPhase 2

NCT07349641

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia…

This phase II trial studies whether adding tirzepatide injections to a levonorgestrel intrauterine device (LNG-IUD) improves pathologic response (absence of can…

United States55 participantsStarted 2026-07-06

Treatment: Medical Device Usage and Evaluation, Tirzepatide

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicente…

All recent trials (11 shown)

A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansi…

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicente…

All recent trials (11 shown)

A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansi…

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia…

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recur…

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia o…

Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplas…

Improving the Treatment for Women With Early Stage Cancer of the Uterus

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial…

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy